Evaluation of Histamine H3 Receptor Radioligand [11C]AZ12807110 and Histamine H3 Receptor Occupancy of AZD5213 After Oral Administration

Clinical trial NCT01194986 · COMPLETED

Trial details

NCT number: NCT01194986
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Distribution of [11C]AZ12807110 and AZD5213

Start date: 2010-11-01
Primary completion: 2011-06-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.